Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The efficiency of OXPHOS is critically dependent on the proper assembly of mitochondrial complexes, significantly influence the immunometabolism and anti-tumor immune activity of immune cells
The elimination half-life was confirmed at under 30 minutes with linear pharmacokinetic characteristics across all tested doses
Third, exercise mimetics can mimic myokines secreted by skeletal muscle, thereby mediating crosstalk among adipose tissue, liver, pancreas, gut, and other important organs
437,438 Sacituzumab govitecan (SG) received its first FDA approval for treating metastatic TNBC patients according to the results of the ASCENT trial
Stock C, Guillen-Grima F, de Mendoza JH, Marin-Fernandez B, Aguinaga-Ontoso I, Kramer A
US$ 21.62
US$ 23.13
US$ 20.90
US$ 24.73
US$ 23.87
